ArticleNeuroradiology2026
Splenial corpus callosum lesions in Boucher-Neuhäuser syndrome: a case series and comprehensive literature review with exploratory analysis of disease duration.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBoucher-Neuhäuser syndrome (BNS) is a rare autosomal recessive neurodegenerative disorder caused by PNPLA6 variants, characterized by cerebellar ataxia, hypogonadotropic hypogonadism, and chorioretinal degeneration. Although cerebellar atrophy is well documented, specific neuroimaging markers remain limited. We aimed to characterize magnetic resonance imaging findings, particularly corpus callosum abnormalities and their association with disease duration.
methodsWe retrospectively analyzed brain MRI from four participants with BNS (two genetically confirmed, two clinically diagnosed) at our institution using 1.5T or 3T scanners with T1-weighted, T2-weighted, fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging sequences. A literature review identified 16 evaluable cases from 14 studies. Cases with multiple sequences were compared descriptively; exploratory Mann-Whitney U tests included single-sequence literature cases.
resultsCerebellar atrophy was universal (20/20, 100%). Splenial corpus callosum signal changes, manifesting as T2WI/FLAIR hyperintensity and/or T1WI hypointensity, were observed in 7/20 (35%) participants, though only 2 were confirmable across multiple sequences. Only 2 of 6 multisequence-evaluable cases met definite criteria; remaining positive literature-derived cases were classified as equivocal owing to single-sequence availability. One participant demonstrated restricted diffusion in corpus callosum lesions. Pituitary gland and stalk atrophy were identified in 6/20 (30%). Participants with corpus callosum abnormalities tended to have longer disease duration (median 25.0 vs. 15.0 years, p = 0.25). The triad-confirmed sensitivity analysis showed a similar trend without statistical significance.
conclusionSplenial signal abnormalities may be under-recognized findings in BNS, potentially associated with longer disease duration. Given the predominance of single-sequence images in the literature, this association remains exploratory and warrants confirmation in larger cohorts.
Indexed as
Identifiers
42435075What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.